Koninklijke DSM NV (Koninklijke DSM NV) ROCE % : 4.56% (As of Dec. 2022)

View and export this data going back to 2001. Start your Free Trial

What is Koninklijke DSM NV ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Koninklijke DSM NV's annualized ROCE % for the quarter that ended in Dec. 2022 was 4.56%.

Koninklijke DSM NV ROCE % Historical Data

The historical data trend for Koninklijke DSM NV's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Koninklijke DSM NV ROCE % Chart

Koninklijke DSM NV Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

11.41

7.88

6.19

5.37

4.94

Koninklijke DSM NV Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
ROCE %	Get a 7-Day Free Trial															5.16	6.31	4.72	5.61	4.56

Koninklijke DSM NV ROCE % Calculation

Koninklijke DSM NV's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	766.949	/	( ( (18101.695 - 2745.763)	+	(18435.381 - 2733.051) )	/ 2 )
	=	766.949	/	( (15355.932	+	15702.33)	/ 2 )
	=	766.949	/	15529.131
	=	4.94 %

Koninklijke DSM NV's ROCE % of for the quarter that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2022 )		(Q: Jun. 2022 )		(Q: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2022 )		(Q: Jun. 2022 )		(Q: Dec. 2022 )
	=	690.678	/	( ( (17815.011 - 3192.389)	+	(18435.381 - 2733.051) )	/ 2 )
	=	690.678	/	( ( 14622.622	+	15702.33 )	/ 2 )
	=	690.678	/	15162.476
	=	4.56 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2022) EBIT data.

Koninklijke DSM NV (OTCPK:RDSMY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Koninklijke DSM NV ROCE % Related Terms

Thank you for viewing the detailed overview of Koninklijke DSM NV's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Koninklijke DSM NV (Koninklijke DSM NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Koninklijke DSM NV (OTCPK:RDSMY) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

KDSKF:USA

Address

Het Overloon 1, P.O. Box 6500, Heerlen, LI, NLD, 6411 TE

Website

https://www.dsm.com

Koninklijke DSM NV is a global, purpose-led company in Health, Nutrition, and Bioscience, applying science to improve the health of people, animals, and the planet. The company delivers innovative business solutions for human and animal nutrition, personal care and aroma, medical devices, green products and applications, new mobility, and connectivity. The company's segment includes Animal Nutrition & Health (ANH), Health, Nutrition & Care (HNC), and Food & Beverage (F&B), where the majority of its revenue is generated from Animal Nutrition & Health (ANH).